Live Breaking News & Updates on Marksans pharma

Stay informed with the latest breaking news from Marksans pharma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Marksans pharma and stay connected to the pulse of your community

Reliance Industries: Vinit Bolinjkar on what's leading to uptick in Reliance Industries

Vinit Bolinjkar, Head of Research at Ventura Securities, cautions against investing in Paytm due to RBI's strong guidance and the company's history of violations and penalties. Positive news on Jio and retail divestment may support Reliance Industries' growth. Marksans Pharma is recommended as a good long-term investment. Marksans is a very good name to be long in, says Bolinjkar

Lucknow , Uttar-pradesh , India , Kozhikode , Kerala , Vinit-bolinjkar , Marksans-pharma , Offering-college , Reliance-industries , Head-of-research , Indian-school-of-business , Ventura-securities

Share Market Highlights 13 February 2024: Sensex climbs 482 pts; Nifty settles above 21,700; banking stocks shine

Share Market Highlights 13 February 2024: Sensex climbs 482 pts; Nifty settles above 21,700; banking stocks shine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Dahej , Gujarat , India , Turkey , Hindustan , India-general- , Taiwan , Bihar , Nirmal , Andhra-pradesh , Italy , Japan

F&O stocks to buy today: Biocon, Info Edge among top 8 trading ideas for 7 February 2024

Positive setup was seen in stocks like SAIL, BPCL, OFSS, Ipca Laboratories, IOC, HPCL, Petronet LNG, Zydus Life, MGL, NALCO, TCS, Maruti Suzuki India and ONGC.

India , Nooresh-merani , Chandan-taparia , Gajendra-prabhu , Etbureaumarksans-pharma , Kunal-bothra , Derivatives-at-motilal-oswal-financial-services , Ipca-laboratories , Zydus-life , Maruti-suzuki-india , Motilal-oswal-financial-services-limited

bank stocks: Lending businesses are on the table, but as portfolio managers staying out of banking space now: Kenneth Andrade

Kenneth Andrade believes that metal converters and Indian companies in the steel industry are a good bet. The balance sheets of these businesses have improved, with increased cash generation and capacity expansion. The key factor for success is the rise in steel prices, which would lead to a recovery in profitability. Additionally, Andrade mentions the growth potential in the premium liquor segment due to per capita rise in income and the trend of premiumization.

Kozhikode , Kerala , India , Lucknow , Uttar-pradesh , Marksans-pharma , Kenneth-andrade , Prime-minister , Indian-school-of-business , Offering-college , Tata-steel , Old-bridge-capital-management

Consistent Gainers: After 20% returns for 4 quarters in a row, 8 stocks turn multibaggers

Hospitality and travel-related stocks gave handsome returns to investors due to the strong rebound in discretionary spending, and RateGain Travel was one among them.

India , Abhinandan-tulsian , Marksans-pharma , Vinay-paharia , Newgen-software , Dalal-street , Ace-equity , Rategain-travel , Gain-travel , Multibaggers , Returns , Wealth

bse healthcare index: 25 stocks hit fresh 52-week high in BSE Healthcare index

At noon, the top gainers in today's trade were Kopran, Marksans Pharma, Unichem Laboratories, and FDC which gained between 8% and 5%. The top losers were Fortis Healthcare, Kovai Medical Center Hospital and Vijaya Diagnostics Centre which fell up to 2.2% around this time.

India , Kovai , Tamil-nadu , Kerala , Astrazeneca-pharma , Aurobindo-pharma , Marksans-pharma , Suven-pharma , Akhil-chaturvedi , Ajanta-pharma , Zydus-lifesciences , Kovai-medical-center-hospital

Nifty hits new milestone; 38 smallcaps gain upto 33%

The short-term technical outlook for Nifty continues to be in favor of the bulls, with support seen at 20089-19909 and resistance at 20500-20751, says Prashanth Tapse, Senior VP (Research), Mehta Equities.

Bombay , Maharashtra , India , Shalimar , West-bengal , China , Himatsingka-seide , Prashanth-tapse , Vinod-nair , Dilip-buildcon , Marksans-pharma , Aether-industries

Global Urinary Retention Therapeutics Industry is projected to hit a remarkable US$ 7.5 billion by 2

Urinary Retention Therapeutics IndustryThe global urinary retention therapeutics industry size is anticipated to attain an impressive valuation of US$ 3.44 billion in 2023 and is projected to reach US$ 7.5 billion by 2033, expected to register a CAGR of 8.11% until 2033, as per a recently published Future Market Ins...

United-states , New-york , Delaware , America , American , Zydus-cadila , Aurobindo-pharma , Marksans-pharma , Ajanta-pharma , Greater-new-york-chamber , Astellas-pharma-europe , Market-insights-inc

Sensex jumps over 600 points, investor wealth jumps Rs 2.2 lakh crore; Aster DM, Adani Total jump up to 18%

The 30-share BSE Sensex pack surged more than 600 points to hit above 66,750 level, while the broader NSE Nifty index moved around 170 points to trade above 20,000. Such was the rise in the domestic bourses that over Rs 2.2 lakh crore of BSE market capitalisation (m-cap) was generated.

Balrampur , Uttar-pradesh , India , Bharti-airtel , Marksans-pharma , Amara-raja-energy-mobility , Axis-bank , Nifty-financial-services , Nifty-bank , Bank-ltd , Tata-motors , Aster-dm-healthcare-ltd

52 week high stocks: Stock market update: Stocks that hit 52-week lows on NSE in today's trade

Adani Ent., ONGC, Divis Labs, Nestle India and Titan Company were among the top losers on NSE in today's trade.

India , Bohra , Uttar-pradesh , Shradha-infraproject , Marksans-pharma , Karda-const , Bohra-industries , Aster-dm-health , Minda-corp , Titan-company , Wipro , Axis-bank